NAD+

NAD+ has been studied in 216 papers since 1987: 7 trials and 5 observational studies in people, 66 in animals, 28 in cells, 107 reviews; 43 in the past year. The newest story, Oct 15, 2026: “Fat-derived protein helped protect muscle in study models”.

Intervention

216 papers study it236 findingsUpdated

PubChemChEBIMeSH

Research on it is growing 48% faster than aging research as a whole: 215 papers in the latest year counted

More supplements

3 new papers in 30 daysSee all 216 papers on NAD+

At a glance

NAD+ extends worm lifespan, a result independent labs reproduce, and improves memory in pathological Tau-bearing mice; human cognitive testing shows no clear effect. One group reports human results. Aging trials are registered; across trials for all uses, a trial remains without posted results over a year after ending, AgelessRx sponsors some trials, and some papers declare company ties.

236 findings in 123 papers from 2000 to 2026, 13 of them since April 2026

The findings reach people, from one lab or study; independent labs found the same change in cells, worms or flies and mice. 59 independent labs in 21 countries; 5 trials, 2 about aging, 1 with no results posted.

“At 1 month, the NAD+ group demonstrated a significantly greater improvement in LVEF compared to the placebo group (45.44 ± 8.55% vs. 42.44 ± 9.09%, p = 0.024).”
Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled TrialAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2025doi:10.1007/s40256-025-00764-7

4 of its findings point the other way.

Cells, worms or flies and mice: replicated by independent labs. Humans: a single group.
  • 59 independent labs in 21 countries
  • 4 findings against
  • 5 trials, 2 about aging, 1 with no results posted
  • Funders: National Natural Science Foundation of China and others
  • 20 of 175 findings with company ties
  • 2 of 5 trials sponsored by its developers
  • Human trial7
  • Humans5
  • Animals60
  • Model organisms6
  • Cells28
  • In silico2

Studies in people

2 studies gave NAD+ to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on cognitive function

up: Improves cognitive functionNAD+ Cohen's d = 5.623–11.986

Randomized trial28 days37 peopleWomenGSA 2025 abstract, Dec 31, 2025

up: Increases left ventricular ejection fraction45.44 ± 8.55% vs 42.44 ± 9.09%, p = 0.024

down: Lowers the risk of major adverse cardiac and cerebrovascular events14.6% vs 24.7%

no change: Has no effect on left ventricular and left atrial dimensions

Randomized trial7 days180 peopleIschemic cardiomyopathy with heart failure, versus placebo, at 1 monthAmerican journal of cardiovascular drugs : drugs, devices, and other interventions, Sep 15, 2025

What did studies of NAD+ find?

179

Studies of NAD+ measured 179 outcomes, among them lifespan, inflammation and oxidative stress and ROS signaling.

Lifespan

upin mice3upin worms3upin animal1upin flies1+1

8 studies
  1. NAD+ extends lifespan (boosting NAD+ levels in various model organisms).

    “Boosting NAD+ levels in various model organisms have resulted in improvements in healthspan and lifespan extension.”

    Reviewboosting NAD+ levels in various model organisms

    NAD⁺ Boosting Strategies

    Sub-cellular biochemistry

  2. NAD+ extends lifespan in mice.

    “NAD+ repletion ameliorates muscular dystrophy and improves the mitochondrial and muscle stem cell function and thereby increase lifespan in mice.”

    Review

    NAD⁺ centric mechanisms and molecular determinants of skeletal muscle disease and aging

    Molecular and cellular biochemistry

  3. NAD+ extends lifespan in mice.

    “NAD+ replenishment can improve the life span of mice.”

    Review

    Nicotinamide Adenine Dinucleotide in the Development and Treatment of Cardiac Remodeling and Aging

    Mini reviews in medicinal chemistry

  4. NAD+ extends lifespan in CS nematode model.

    “significantly improved lifespan and healthspan in the CS nematodes”

    Model organismsin CS nematode model

    Cockayne syndrome proteins CSA and CSB maintain mitochondrial homeostasis through NAD⁺ signaling

    Aging cell

  5. NAD+ extends lifespan in animal (adoptive CAR-T model and immune checkpoint blockade treatment models in vivo).

    “extended animal survive in both adoptive CAR-T model and immune checkpoint blockade treatment models in vivo”

    Animalsadoptive CAR-T model and immune checkpoint blockade treatment models in vivo

    Potentiating the anti-tumor response of tumor infiltrated T cells by NAD + supplementation

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  6. NAD+ extends lifespan in flies (Werner syndrome model).

    “NAD+ repletion remarkably extends lifespan and delays accelerated aging, including stem cell dysfunction, in Caenorhabditis elegans and Drosophila melanogaster models of WS.”

    Model organismsWerner syndrome model

    NAD⁺ augmentation restores mitophagy and limits accelerated aging in Werner syndrome

    Nature communications

  7. NAD+ extends lifespan in worms (Werner syndrome model).

    “NAD+ repletion remarkably extends lifespan and delays accelerated aging, including stem cell dysfunction, in Caenorhabditis elegans and Drosophila melanogaster models of WS.”

    Model organismsWerner syndrome model

    NAD⁺ augmentation restores mitophagy and limits accelerated aging in Werner syndrome

    Nature communications

  8. NAD+ extends lifespan in mice.

    “NAD+ was also demonstrated by the authors to improve the life span of mice.”

    Review

    NAD⁺ : A big player in cardiac and skeletal muscle remodeling and aging

    Journal of cellular physiology

  9. NAD+ extends lifespan in worms (genetic or pharmacological restoration).

    “pharmacological restoration of NAD(+) prevents age-associated metabolic decline and promotes longevity in worms”

    Model organismsgenetic or pharmacological restoration

    The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling

    Cell

Inflammation

downin mice4downin pigs1downin rats1downin Rattus norvegicus; Mus musculus1+1

8 studies
  1. NAD+ decreases inflammation in high-fat diet-fed ApoE-/- mice.

    “NAD+ alleviated oxidative stress, fibrosis, inflammation and apoptosis”

    Animalsin high-fat diet-fed ApoE-/- micemyocardium16 weeks

    High‑intensity exercise training inhibits excessive autophagy in the hyperlipidemic myocardium of ApoE‑/‑ mice via the NAD⁺‑mediated SIRT1/MFN2 pathway

    Molecular medicine reports

  2. NAD+ decreases inflammation in Rattus norvegicus; Mus musculus (rodent models of AD, TBI, diabetes, aging, VAD and schizophrenia).

    “Studies have revealed that treatment with NAD+ rescues cognitive deficits by inhibiting inflammation, oxidative stress, and apoptosis and improving mitochondrial function.”

    Reviewrodent models of AD, TBI, diabetes, aging, VAD and schizophrenia

    A systematic review of the therapeutic potential of nicotinamide adenine dinucleotide precursors for cognitive diseases in preclinical rodent models

    BMC neuroscience

  3. NAD+ decreases inflammation in mice (experimental autoimmune encephalomyelitis).

    “NAD + alleviated neuroinflammation, attenuated central nervous system (CNS) demyelination, and improved the disease score of EAE mice.”

    Animalsexperimental autoimmune encephalomyelitiscentral nervous system250 mg/kg/day

    NAD+ attenuates central nervous system demyelination in experimental autoimmune encephalomyelitis mice

    Folia neuropathologica

  4. NAD+ decreases inflammation in mice.

    “Recent evidence has revealed that the adipose tissue could be another direct target of NAD supplementation by attenuating inflammation and fat accumulation.”

    Reviewwhite adipose tissue

    Function of NAD metabolism in white adipose tissue: lessons from mouse models

    Adipocyte

  5. NAD+ decreases inflammation in mice (EAE).

    “key inflammation was ameliorated in EAE mice spleen after NAD+ intervention”

    AnimalsEAEspleen

    NAD⁺ affects differentially expressed genes-MBOAT2-SLC25A21-SOX6 in experimental autoimmune encephalomyelitis model

    The International journal of neuroscience

  6. NAD+ decreases inflammation (boosting NAD+ levels, hedged as a possibility).

    “interventions that boost NAD+ levels might promote antiviral defense and suppress uncontrolled inflammation”

    Reviewboosting NAD+ levels, hedged as a possibility

    NAD⁺ in COVID-19 and viral infections

    Trends in immunology

  7. NAD+ inhibits inflammation in chronic cerebral hypoperfusion (CCH) models.

    “inhibited neuroinflammation by protecting mitochondria and decreasing ROS production in CCH rats”

    Animalsin chronic cerebral hypoperfusion (CCH) modelsbrain8 weeks

    NAD⁺ improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway

    Journal of neuroinflammation

  8. NAD+ decreases inflammation in pigs after 90 min balloon occlusion and reperfusion.

    “The extent of inflammation was also reduced in the NAD+ treated animals”

    Animalsafter 90 min balloon occlusion and reperfusionmyocardium20 mg/kg

    Exogenous supplemental NAD+ protect myocardium against myocardial ischemic/reperfusion injury in swine model

    American journal of translational research

More on Inflammation

Oxidative stress and ROS signaling

downin reviews2downin human cells1downin mice1downin rats1+1

6 studies
  1. NAD+ decreases oxidative stress and ROS signaling in cardiomyocytes exposed to doxorubicin.

    “NAD+ supplementation preserved cardiomyocyte viability, reduced oxidative stress”

    Cellsin cardiomyocytes exposed to doxorubicincardiomyocyte

    NAD+ supplementation improves cardiomyocyte resilience to doxorubicin-induced cardiotoxicity

    ESC Congress 2026 abstract

  2. NAD+ decreases oxidative stress and ROS signaling in high-fat diet-fed ApoE-/- mice.

    “NAD+ alleviated oxidative stress, fibrosis, inflammation and apoptosis”

    Animalsin high-fat diet-fed ApoE-/- micemyocardium16 weeks

    High‑intensity exercise training inhibits excessive autophagy in the hyperlipidemic myocardium of ApoE‑/‑ mice via the NAD⁺‑mediated SIRT1/MFN2 pathway

    Molecular medicine reports

  3. NAD+ decreases oxidative stress and ROS signaling in Rattus norvegicus; Mus musculus (rodent models of AD, TBI, diabetes, aging, VAD and schizophrenia).

    “Studies have revealed that treatment with NAD+ rescues cognitive deficits by inhibiting inflammation, oxidative stress, and apoptosis and improving mitochondrial function.”

    Reviewrodent models of AD, TBI, diabetes, aging, VAD and schizophrenia

    A systematic review of the therapeutic potential of nicotinamide adenine dinucleotide precursors for cognitive diseases in preclinical rodent models

    BMC neuroscience

  4. NAD+ decreases oxidative stress and ROS signaling.

    “NAD+ exerts considerable antiaging and antioxidant effects with promising therapeutic effects.”

    Review

    Nicotinamide Adenine Dinucleotide in the Development and Treatment of Cardiac Remodeling and Aging

    Mini reviews in medicinal chemistry

  5. NAD+ decreases oxidative stress and ROS signaling in chronic cerebral hypoperfusion (CCH) models.

    “NAD+ administration rescued cognitive deficits and inhibited neuroinflammation by protecting mitochondria and decreasing ROS production in CCH rats”

    Animalsin chronic cerebral hypoperfusion (CCH) modelsbrain8 weeks

    NAD⁺ improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway

    Journal of neuroinflammation

  6. NAD+ decreases oxidative stress and ROS signaling.

    “NAD+ produces its beneficial effects by targeting at multiple pathological pathways, including attenuating mitochondrial alterations, DNA damage, and oxidative stress”

    Review

    NAD⁺ Deficiency Is a Common Central Pathological Factor of a Number of Diseases and Aging: Mechanisms and Therapeutic Implications

    Antioxidants & redox signaling

More on Oxidative stress and ROS signaling

Cognitive function

upin humans1no changein humans1upin rats1upin Rattus norvegicus; Mus musculus1

3 studies
  1. NAD+ improves cognitive function in humans (pre-post change within the NAD+ group, not relative to placebo) (NAD+ Cohen's d = 5.623–11.986).

    “Paired-samples t-tests revealed significant pre-post improvements across all measures”

    Human trialpre-post change within the NAD+ group, not relative to placebo28 daysfemalesn = 37

    A Double-Blind Trial to Test if NAD+ Improves Cognition

    GSA 2025 abstract

  2. NAD+ showed no clear effect on cognitive function in humans (compared with placebo, adjusted for baseline).

    “Findings suggest NAD+ supplementation did not improve cognition more than the placebo.”

    Human trialcompared with placebo, adjusted for baseline28 daysfemalesn = 37

    A Double-Blind Trial to Test if NAD+ Improves Cognition

    GSA 2025 abstract

  3. NAD+ improves cognitive function in Rattus norvegicus; Mus musculus (rodent models of AD, TBI, diabetes, aging, VAD and schizophrenia).

    “Studies have revealed that treatment with NAD+ rescues cognitive deficits by inhibiting inflammation, oxidative stress, and apoptosis and improving mitochondrial function.”

    Reviewrodent models of AD, TBI, diabetes, aging, VAD and schizophrenia

    A systematic review of the therapeutic potential of nicotinamide adenine dinucleotide precursors for cognitive diseases in preclinical rodent models

    BMC neuroscience

  4. NAD+ improves cognitive function in chronic cerebral hypoperfusion (CCH) models.

    “NAD+ administration rescued cognitive deficits”

    Animalsin chronic cerebral hypoperfusion (CCH) modelsbrain8 weeks

    NAD⁺ improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway

    Journal of neuroinflammation

Mitophagy

upin mice1upin model organisms1upin worms1

3 studies
  1. NAD+ increases mitophagy in mice.

    “increased cellular mitophagy in both neurons and astrocytes in old-aged male mice”

    Animalssomatosensory cortexmales

    Mitochondrial recycling declined in older mouse brain cells

    npj aging

  2. NAD+ increases mitophagy (dependent on DCT-1 and ULK-1).

    “NAD+ repletion restores NAD+ metabolic profiles and improves mitochondrial quality through DCT-1 and ULK-1-dependent mitophagy.”

    Model organismsdependent on DCT-1 and ULK-1

    NAD⁺ augmentation restores mitophagy and limits accelerated aging in Werner syndrome

    Nature communications

  3. NAD+ activates mitophagy in C. elegans.

    “In C. elegans, NAD+ repletion can clear accumulated dysfunctional mitochondria through restoration of compromised mitophagy via upregulation of DCT-1”

    Model organismsin C. elegans

    NAD⁺: The convergence of DNA repair and mitophagy

    Autophagy

More on Mitophagy

Autophagy

upin animals1upin mice1upin reviews1

3 studies
  1. NAD+ activates autophagy (via EVA1C isoforms interacting with BAG1 and HSPA/HSP70).

    “reinforcing their network to facilitate chaperone-assisted selective macroautophagy and proteasomal degradation of misfolded proteins such as MAPT/tau”

    Animalsvia EVA1C isoforms interacting with BAG1 and HSPA/HSP70

    NAD⁺ restores proteostasis through splicing-dependent autophagy

    Autophagy

  2. NAD+ increases autophagy in EAE mice, decreased autophagy markers reversed by NAD+.

    “decreased P62, Beclin1, LC-3A/B and SIRT1, and NAD+ reversed these results”

    Animalsin EAE mice, decreased autophagy markers reversed by NAD+thymus

    NAD+ improved experimental autoimmune encephalomyelitis by regulating SIRT1 to inhibit PI3K/Akt/mTOR signaling pathway

    Aging

  3. NAD+ activates autophagy.

    “NAD+ has stimulatory effects on stress protein expression and autophagy”

    Review

    Mitochondrial dysfunction, proteotoxicity, and aging: causes or effects, and the possible impact of NAD+-controlled protein glycation

    Advances in clinical chemistry

More on Autophagy

Glycolysis

upin cells1downin human cells1upin mouse cells1

3 studies
  1. NAD+ increases glycolysis in NMNAT2 knockout neurons.

    “Exogenous NAD+ supplementation to NMNAT2 KO neurons restores glycolysis and resumes fast axonal transport.”

    Cellsin NMNAT2 knockout neuronsexogenous

    NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport

    Molecular neurodegeneration

  2. NAD+ decreases glycolysis in human cells.

    “NAD+ simultaneously increases hESC mitochondrial oxidative metabolism and partially suppresses glycolysis”

    Cells

    Nicotinamide adenine dinucleotide induces a bivalent metabolism and maintains pluripotency in human embryonic stem cells

    Stem cells (Dayton, Ohio)

  3. NAD+ increases glycolysis in cells.

    “The HMGA-NAMPT-NAD+ signalling axis promotes the proinflammatory SASP by enhancing glycolysis and mitochondrial respiration.”

    Cells

    NAD⁺ metabolism governs the proinflammatory senescence-associated secretome

    Nature cell biology

More on Glycolysis

Healthspan

upin reviews2upin worms1

3 studies
  1. NAD+ improves healthspan (boosting NAD+ levels in various model organisms).

    “Boosting NAD+ levels in various model organisms have resulted in improvements in healthspan and lifespan extension.”

    Reviewboosting NAD+ levels in various model organisms

    NAD⁺ Boosting Strategies

    Sub-cellular biochemistry

  2. NAD+ improves healthspan in CS nematode model.

    “significantly improved lifespan and healthspan in the CS nematodes”

    Model organismsin CS nematode model

    Cockayne syndrome proteins CSA and CSB maintain mitochondrial homeostasis through NAD⁺ signaling

    Aging cell

  3. NAD+ improves healthspan.

    “discuss how boosting NAD+ content can help ameliorate mitochondrial homeostasis and as such improve healthspan and lifespan”

    Review

    Modulating NAD⁺ metabolism, from bench to bedside

    The EMBO journal

DNA repair

upin humans1upin reviews1is required forin reviews1

3 studies
  1. NAD+ improves DNA repair in humans (disease progression in neurodegenerative conditions).

    “administratering NAD+ or its precursors endogenously may potentially prevent and slow disease progression by enhancing DNA repair and improving mitochondrial function.”

    Reviewdisease progression in neurodegenerative conditions

    Therapeutic potential of NADH: in neurodegenerative diseases characterizde by mitochondrial dysfunction

    Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery

  2. NAD+ improves DNA repair.

    “In this article, we concisely and critically review the role of NAD+ in mechanisms promoting genome maintenance.”

    Review

    Fueling genome maintenance: On the versatile roles of NAD⁺ in preserving DNA integrity

    The Journal of biological chemistry

  3. NAD+ is required for DNA repair.

    “We discuss how cellular NAD+ is required for BER to maintain genome stability and to mount a robust cellular response to DNA damage.”

    Review

    NAD⁺-mediated regulation of mammalian base excision repair

    DNA repair

More on DNA repair

Oxidative phosphorylation

upin cells2upin human cells1

3 studies
  1. NAD+ increases oxidative phosphorylation in cells.

    “Short-term incubation with NAD+ boosts Kreb's cycle and the electron transport chain and enhances pyrimidine biosynthesis.”

    Cellsshort-term

    NAD⁺ regulates nucleotide metabolism and genomic DNA replication

    Nature cell biology

  2. NAD+ increases oxidative phosphorylation in human cells.

    “NAD+ simultaneously increases hESC mitochondrial oxidative metabolism and partially suppresses glycolysis”

    Cells

    Nicotinamide adenine dinucleotide induces a bivalent metabolism and maintains pluripotency in human embryonic stem cells

    Stem cells (Dayton, Ohio)

  3. NAD+ increases oxidative phosphorylation in cells.

    “The HMGA-NAMPT-NAD+ signalling axis promotes the proinflammatory SASP by enhancing glycolysis and mitochondrial respiration.”

    Cells

    NAD⁺ metabolism governs the proinflammatory senescence-associated secretome

    Nature cell biology

More on Oxidative phosphorylation

Age-related cardiomyopathy

downin humans1downin rodents1

1 study
  1. NAD+ protects against age-related cardiomyopathy in humans (restoring NAD levels).

    “Restoring nicotinamide adenine dinucleotide levels rescues lysosomal acidification and CL metabolism, protecting against age-related cardiomyopathy in rodents and humans.”

    Human trialrestoring NAD levelsheart

    Vacuolar H⁺-ATPase Preserves Cardiolipin Homeostasis Through the Lysosomal-Mitochondrial Axis to Restrain Cardiac Aging

    Circulation

  2. NAD+ protects against age-related cardiomyopathy in rodents (restoring NAD levels).

    “Restoring nicotinamide adenine dinucleotide levels rescues lysosomal acidification and CL metabolism, protecting against age-related cardiomyopathy in rodents and humans.”

    Animalsrestoring NAD levelsheart

    Vacuolar H⁺-ATPase Preserves Cardiolipin Homeostasis Through the Lysosomal-Mitochondrial Axis to Restrain Cardiac Aging

    Circulation

More on Age-related cardiomyopathy

Left ventricular and left atrial dimensions

no changein humans1

1 study
  1. NAD+ showed no clear effect on left ventricular and left atrial dimensions in humans (ischemic cardiomyopathy with heart failure, versus placebo).

    “No significant differences were observed in structural parameters (left ventricular end-diastolic diameter, left ventricular end-diastolic volume, left atrial diameter).”

    Human trialischemic cardiomyopathy with heart failure, versus placebointravenousheart10 mg/day7 daysn = 180

    Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial

    American journal of cardiovascular drugs : drugs, devices, and other interventions

Left ventricular ejection fraction

upin humans1

1 study
  1. NAD+ increases left ventricular ejection fraction in humans (ischemic cardiomyopathy with heart failure, versus placebo, at 1 month) (45.44 ± 8.55% vs 42.44 ± 9.09%, p = 0.024).

    “At 1 month, the NAD+ group demonstrated a significantly greater improvement in LVEF compared to the placebo group (45.44 ± 8.55% vs. 42.44 ± 9.09%, p = 0.024).”

    Human trialischemic cardiomyopathy with heart failure, versus placebo, at 1 monthintravenousheart10 mg/day7 daysn = 180

    Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial

    American journal of cardiovascular drugs : drugs, devices, and other interventions

White blood cell and neutrophil counts

upin humans1

1 study
  1. NAD+ increases white blood cell and neutrophil counts in humans (acute NAD+ IV infusion).

    “an increase in white blood cell counts and neutrophils was observed in the NAD+ IV condition”

    Human trialacute NAD+ IV infusionintravenous500 mg

    Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen®+ IV and NAD+ IV in healthy adults

    medRxivPreprint

More on White blood cell and neutrophil counts

All 179

What is NAD+ linked with?

8

Studies link NAD+ with 8 measures, among them Nonlinear NAD+ response, major adverse cardiac and cerebrovascular events and DBC1.

Nonlinear NAD+ response

mixedin reviews1

1 study
  1. NAD+ is associated with nonlinear NAD+ response (modelling framework; dose, age, metabolic state and route of administration).

    “NAD+ responses are nonlinear and influenced by factors such as dose, age, metabolic state, and route of administration.”

    Reviewmodelling framework; dose, age, metabolic state and route of administration

    NAD⁺ biology and supplementation: From mechanisms to clinical perspectives

    Molecular biology reports

Major adverse cardiac and cerebrovascular events

downin humans1

1 study
  1. NAD+ lowers the risk of major adverse cardiac and cerebrovascular events in humans (ischemic cardiomyopathy with heart failure, versus placebo, over 6 months) (14.6% vs 24.7%).

    “The 6-month composite MACCE rate appeared lower among those receiving NAD+ treatment compared to the placebo group (14.6% vs. 24.7%, p = 0.089).”

    Human trialischemic cardiomyopathy with heart failure, versus placebo, over 6 monthsintravenous10 mg/day7 daysn = 180

    Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial

    American journal of cardiovascular drugs : drugs, devices, and other interventions

DBC1

upin human cells1

1 study
  1. NAD+ is associated with DBC1 in human cells (NHD domain fragment DBC1354-396, measured by NMR and ITC) (binding affinity 8.99 μM, nearly twice that of NMN (17.0 μM)).

    “NAD+ likely interacts with DBC1354−396 through hydrogen bonding, with a binding affinity (8.99 μM) nearly twice that of NMN (17.0 μM)”

    CellsNHD domain fragment DBC1354-396, measured by NMR and ITC

    Molecular mechanism of NAD⁺ and NMN binding to the Nudix homology domains of DBC1

    International journal of biological macromolecules

More on DBC1

Myocardial infarction

downin rats1

1 study
  1. NAD+ lowers the risk of myocardial infarction in heart failure following myocardial infarction.

    “Medium and highdose NAD+ showed superior positive effects on myocardial hypertrophy, cardiac function, and myocardial fibrosis and reduced the MI rate.”

    Animalsin heart failure following myocardial infarction4 weeksmales

    The Role of NAD⁺ in Myocardial Ischemia-induced Heart Failure in Sprague-dawley Rats and Beagles

    Current pharmaceutical biotechnology

More on Myocardial infarction

Chronic kidney disease

mixedin reviews1

1 study
  1. NAD+ is associated with chronic kidney disease.

    “although conflicting results exist for cases of CKD”

    Review

    Roles of NAD⁺ in Acute and Chronic Kidney Diseases

    International journal of molecular sciences

More on Chronic kidney disease

Endothelial cell origin, species and culture type

mixedin cells1

1 study
  1. NAD+ is associated with endothelial cell origin, species and culture type in cells across vessel origin, species and culture type.

    “We showed profound differences in extracellular NAD+ and NMN metabolism related to the vessel origin, species diversity, and type of culture.”

    Cellsacross vessel origin, species and culture type

    Differences in Extracellular NAD⁺ and NMN Metabolism on the Surface of Vascular Endothelial Cells

    Biology

Poor COVID-19 outcomes

upin reviews1

1 study
  1. NAD+ is associated with poor COVID-19 outcomes (low NAD+ concentrations).

    “We discuss the association between low NAD+ concentrations and risk factors for poor COVID-19 outcomes, including aging and common comorbidities.”

    Reviewlow NAD+ concentrations

    NAD⁺ in COVID-19 and viral infections

    Trends in immunology

Acute kidney injury

downin reviews1

1 study
  1. NAD+ lowers the risk of acute kidney injury (restoring mitochondrial homeostasis and increasing NAD+ availability).

    “Experimental and clinical studies have shown that by restoring mitochondrial homeostasis and increasing renal tubulo-epithelial cells, NAD+ availability, AKI incidence, and chronic long-term complications are significantly decreased.”

    Reviewrestoring mitochondrial homeostasis and increasing NAD+ availabilitykidney

    Innovations and Emerging Therapies to Combat Renal Cell Damage: NAD⁺ As a Drug Target

    Antioxidants & redox signaling

More on Acute kidney injury

What acts on NAD+?

1

Studies name HEK293 cells as acting on NAD+.

HEK293 cells

downin human cells1

1 study
  1. HEK293 cells decrease NAD+ in human cells (serum-free culture medium).

    “When cultivated in serum-free medium, HEK293 cells efficiently cleaved NAD+ and NAAD to NMN and NAMN.”

    Cellsserum-free culture medium

    Degradation of Extracellular NAD⁺ Intermediates in Cultures of Human HEK293 Cells

    Metabolites

Has NAD+ been tested in people?

2 of 5 about aging

Yes: 7 trials and 5 observational studies in people have been published, and 5 trials are registered.

Every condition in trials

  • Unresectable HepatoCellular Carcinoma

    Phase 4Status unknown1 trial

  • Aging

    Phase 3Completed1 trial

  • Healthspan improvement

    Phase 3Completed1 trial

  • Longevity

    Phase 3Completed1 trial

  • COVID-19

    Phase 2Completed1 trial

  • Post-acute COVID-19 syndrome

    Phase 2Completed1 trial

All 7

Trial sponsors

Funding

90 grants since 2016

National Institute on Aging$31.1MJapan Society for the Promotion of Science¥140MNational Institute of Diabetes and Digestive and Kidney Diseases$7.5M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    NAD+ extends worm lifespan with independent replication and reduces DNA damage during aging in mice; one group reports increased inflammation in humans, contrasting with independently replicated reductions in rats. Two registered trials concern aging; a trial ended over a year ago without posted results. Some authors have company affiliations, papers declare company ties, and AgelessRx sponsors trials.

  2. Summary rewritten as its findings changed.

    As it read before

    A review describes short-term NAD+ use in humans as increasing NAD+ levels and inducing nausea.

  3. Summary written from the findings.

Latest

Dec 2025: 1Jan 2026: 5Feb 2026: 2Mar 2026: 3Apr 2026: 5May 2026: 6Jun 2026: 7Jul 2026: 3Aug 2026: 1Sep 2026: 3Oct 2026: 3Nov 2026: 140 papers in 12 months
Cell Metabolism

Fat-derived protein helped protect muscle in study models

Research in models of aging, disuse and cancer-related wasting identified a fat-derived protein as a key mediator of protection from a metabolic supplement.Research in models of aging, disuse and cancer-related wasting identified a fat-derived protein as a key mediator of protection from a metabolic supplement.

Experiments in animalsMuscle

See all 216 papers on NAD+